Confirmed Activity and Tolerability of Weekly Paclitaxel in the Treatment of Advanced Angiosarcoma

Background. In several prospective and retrospective studies, weekly paclitaxel showed promising activity in patients with angiosarcoma. Patients and Methods. Our study was originally designed as a prospective, phase II multicenter trial for patients younger than 75, with ECOG performance status 0–2...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sarcoma
Main Authors: Apice, Gaetano, Pizzolorusso, Antonio, Di Maio, Massimo, Grignani, Giovanni, Gebbia, Vittorio, Buonadonna, Angela, De Chiara, Annarosaria, Fazioli, Flavio, De Palma, Giampaolo, Galizia, Danilo, Arcara, Carlo, Mozzillo, Nicola, Perrone, Francesco
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi Publishing Corporation 2016
Assuntos:
Clinical Study
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4785388/
https://ncbi.nlm.nih.gov/pubmed/27019606
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/6862090
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados